IMMUNOLOGY KIT NEURON-SPECIFIC ENOLASE NSE (CLIA) - COFEPRIS Registration 2224R2021 SSA
Access comprehensive regulatory information for IMMUNOLOGY KIT NEURON-SPECIFIC ENOLASE NSE (CLIA) (IMMUNOLOGY KIT NEURON-SPECIFIC ENOLASE NSE (CLIA)) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 2224R2021 SSA and manufactured by MINDRAY MEDICALMÉXICO, S. DE R.L. DEC.V.. The device was registered on December 30, 2021.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL ENSAYO NSE DE LA SERIE CL ES UNINMUNOENSAYO QUIMIOLUMINISCENTE(CLIA) PARA LA DETERMINACIÓNCUANTITATIVA DE LA ENOLASA ESPECÍFICA DE NEURONAS (NSE) EN PLASMA O SUEROHUMANO. AGENTE DE DIAGNÓSTICO INVITRO PARA USO EXCLUSIVO ENLABORATORIO CLÍNICO O DE GABINETE.
THE CL SERIES NSE ASSAY IS A CHEMILUMINESCENT IMMUNOASSAY (CLIA) FOR THE QUANTITATIVE DETERMINATION OF NEURON-SPECIFIC ENOLASE (NSE) IN PLASMA OR HUMAN SERUM. INVITRO DIAGNOSTIC AGENT FOR EXCLUSIVE USE IN CLINICAL LABORATORY OR CABINET.